Paloma Partners Management CO Cti Biopharma Corp Transaction History

Paloma Partners Management CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$1.02 - $2.15 $30,894 - $65,121	-30,289 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$0.88 - $1.32 $26,654 - $39,981	30,289 New	30,289 $35,000
Q4 2019 Feb 14, 2020	SELL	$0.72 - $1.64 $116,096 - $264,441	-161,245 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$0.64 - $0.92 $43,875 - $63,070	-68,555 Reduced 29.83%	161,245 $134,000
Q2 2019 Aug 14, 2019	BUY	$0.8 - $1.03 $183,840 - $236,694	229,800 New	229,800 $197,000

Ticker CTIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 114,385,000
Market Cap $1.04B
Description
CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients w...

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

Stay updated on Paloma Partners Management CO with notifications on news.